InsiderClue
Insiders · Profile

Davis Andrew

SVP, Chief Business Officer at IRONWOOD PHARMACEUTICALS. Filing since 21 Nov 2022. CIK 0001932525

Company
Date
Role
Action
Shares
Amount
Of holding
IRWD IRONWOOD PHARMACEUTICALS INC
18 Nov 2024
SVP, Chief Business Officer
Sold at will
5,360
$21.87K
1.8%
IRWD IRONWOOD PHARMACEUTICALS INC
20 May 2024
SVP, Chief Business Officer
Sold at will
22,725
$146.58K
7.3%
IRWD IRONWOOD PHARMACEUTICALS INC
12 Feb 2024
SVP, Chief Business Officer
Sold at will
9,846
$150.05K
4.5%
IRWD IRONWOOD PHARMACEUTICALS INC
20 Nov 2023
SVP, Chief Business Officer
Sold at will
3,287
$31.85K
1.5%
IRWD IRONWOOD PHARMACEUTICALS INC
22 May 2023
SVP, Chief Business Officer
Sold at will
6,305
$63.81K
2.8%
IRWD IRONWOOD PHARMACEUTICALS INC
28 Feb 2023
SVP, Chief Business Officer
Sold, plan not stated
1,822
$20.61K
1.2%
IRWD IRONWOOD PHARMACEUTICALS INC
27 Feb 2023
SVP, Chief Business Officer
Sold, plan not stated
1,751
$19.98K
1.1%
IRWD IRONWOOD PHARMACEUTICALS INC
21 Nov 2022
SVP, Chief Business Officer
Sold, plan not stated
3,335
$38.55K
2.1%
8 decisions on file.